About
Chris joined Flagship in 2007 as Partner and focuses primarily on Life Science investments. He came to Flagship with significant management experience in clinical development, regulatory strategy, business development, sales, and marketing in the pharmaceutical industry. Prior to Flagship, Chris was with Novartis Pharmaceuticals since 2004 where he served most recently as Director of the Tekturna (aliskiren) marketing team responsible for all Medical Marketing, Medical Strategy, and Professional Promotions activities in the U.S. Chris also oversaw Tekturna�s extensive clinical development programs, and played a key role in the FDA approval, CMS reimbursement coverage approval, and successful commercial launch of Tekturna in early 2007. Previously at Novartis, Chris was Director of Business Development & Licensing where he identified several in-licensing opportunities and drove key transactions. Prior to that, Chris focused on corporate strategy working directly with the Novartis Pha
Position in the VCSift Database
- • 44 investors hold the Founder, President & CEO role in VCSift. Chris Varma is one of them.
- • 1,751 investors are based in California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- California, US
Contact Information
Find more investors like Chris
Search Investors